AstraZeneca Joins ACRP Workforce Development Steering Committee Defining Competence Standards for Clinical Trials Professionals

AstraZeneca

The Association of Clinical Research Professionals (ACRP) today announces AstraZeneca as the latest member of the multi-stakeholder ACRP Workforce Development Steering Committee.

The Steering Committee is charged with reviewing and approving core competence standards for clinical research professionals developed by the ACRP Workforce Development Task Force, whose contributors include broad representation from leading industry and academic organizations across the global clinical research enterprise.

“AstraZeneca is eager to collaborate in the important work of defining competence for clinical research professionals,” says Doug Schantz, Executive Director, Clinical Operations. “This will support continuous quality improvement and enhance the confidence of patients who depend on medicines from our industry.”

“ACRP is excited to announce AstraZeneca as a member of the ACRP Workforce Development Steering Committee,” says Terri Hinkley, RN, BScN, MBA, CCRC, FACRP, ACRP’s Workforce Innovation Officer. “We are thankful for AstraZeneca’s willingness to support workforce competence standardization as a means of promoting excellence in clinical research.”

As its first initiative, the Task Force and Steering Committee will request public comment on a competence framework for Clinical Research Associates (CRAs). This framework will define standards for clinical trial monitors/CRAs within the eight core competence domains for clinical research professionals, as defined by the Joint Task Force for Clinical Trial Competence.

ACRP invites additional Steering Committee participation from executives and senior management at clinical trial sponsors. Interested parties should contact Terri Hinkley, RN, BScN, MBA, CCRC, FACRP, ACRP’s Workforce Innovation Officer, at thinkley@acrpnet.org.

CONTACT:
Jeremy Glunt
+ 1.703.258.3506
media@acrpnet.org